WROBLESKI, STEPHEN T.,DAS, JAGABANDHU,DUAN, JINGWU,GUO, JUNQING,HYNES, JOHN,JIANG, BIN,KEMPSON, JAMES,LIN, SHU-QUN,LU, ZHONGHUI,PITTS, WILLIAM J.,SPERGEL, STEVEN H.,WU, HONG,YANG, BINGWEI VERA
申请号:
TW101109227
公开号:
TW201249846A
申请日:
2012.03.16
申请国别(地区):
TW
年份:
2012
代理人:
摘要:
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of JAK3, thereby making them useful for the treatment of inflammatory and autoimmune diseases.